Lsv Asset Management Boosted Dana (DAN) Position By $3.32 Million; Last Week Ironwood Pharmaceuticals, Inc. (IRWD) Analysts

February 15, 2018 - By Richard Conner

Among 15 analysts covering Ironwood Pharmaceuticals (NASDAQ:IRWD), 4 have Buy rating, 2 Sell and 9 Hold. Therefore 27% are positive. Ironwood Pharmaceuticals had 37 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by Mizuho on Monday, October 10. The stock has “Sell” rating by Bank of America on Friday, January 5. Mizuho maintained it with “Buy” rating and $20 target in Friday, November 4 report. The firm earned “Hold” rating on Tuesday, January 9 by Mizuho. Mizuho maintained Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) on Tuesday, June 6 with “Buy” rating. The firm has “Neutral” rating by JP Morgan given on Friday, July 21. The company was maintained on Friday, February 19 by Barclays Capital. The stock of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) earned “Buy” rating by Mizuho on Friday, July 15. Mizuho downgraded the shares of IRWD in report on Wednesday, December 6 to “Neutral” rating. The firm has “Neutral” rating by Wedbush given on Monday, October 24. See Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) latest ratings:

09/01/2018 Broker: Mizuho Rating: Hold New Target: $16.0 Maintain
05/01/2018 Broker: Bank of America Rating: Sell New Target: $15.0 Downgrade
06/12/2017 Broker: Mizuho Old Rating: Buy New Rating: Neutral Downgrade
04/12/2017 Broker: BTIG Research Rating: Buy New Target: $21.0
04/12/2017 Broker: Morgan Stanley Rating: Hold
27/11/2017 Broker: Credit Suisse Rating: Outperform New Target: $19 Initiates Coverage On
01/11/2017 Broker: Cowen & Co Rating: Buy New Target: $20.0 Maintain
06/10/2017 Broker: Mizuho Rating: Buy New Target: $20.0 Maintain
21/08/2017 Broker: Cowen & Co Rating: Buy New Target: $20.0 Maintain

Lsv Asset Management increased Dana Incorporated (DAN) stake by 8.17% reported in 2017Q3 SEC filing. Lsv Asset Management acquired 123,100 shares as Dana Incorporated (DAN)’s stock rose 1.03%. The Lsv Asset Management holds 1.63 million shares with $45.58M value, up from 1.51 million last quarter. Dana Incorporated now has $4.11B valuation. The stock decreased 0.91% or $0.26 during the last trading session, reaching $28.34. About 1.05 million shares traded. Dana Incorporated (NYSE:DAN) has risen 70.12% since February 15, 2017 and is uptrending. It has outperformed by 53.42% the S&P500.

Since August 18, 2017, it had 0 insider purchases, and 3 insider sales for $983,540 activity. On Tuesday, September 5 OLANOFF LAWRENCE S sold $32,300 worth of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) or 2,000 shares. Consylman Gina sold $2,968 worth of stock. $24,240 worth of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) was sold by McHugh Julie. The insider Currie Mark G sold $927,000.

Investors sentiment decreased to 1.25 in 2017 Q3. Its down 0.06, from 1.31 in 2017Q2. It is negative, as 24 investors sold Ironwood Pharmaceuticals, Inc. shares while 32 reduced holdings. 13 funds opened positions while 57 raised stakes. 154.60 million shares or 6.92% more from 144.60 million shares in 2017Q2 were reported. Gp has 90,291 shares. Jane Street Gp Lc has 0% invested in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Rhumbline Advisers has invested 0.01% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Voya Investment Management Ltd Com has invested 0% of its portfolio in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Prudential Fincl holds 14,564 shares or 0% of its portfolio. Gotham Asset Ltd Llc owns 34,314 shares or 0.01% of their US portfolio. Australia-based Platinum Invest Management Limited has invested 0.04% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). D E Shaw And Com has 291,857 shares. Schwab Charles Invest holds 639,299 shares or 0.01% of its portfolio. Blackrock Inc has 0.01% invested in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). 192,000 are owned by Eventide Asset Management Ltd. Teacher Retirement System Of Texas accumulated 0% or 10,550 shares. 2,900 were accumulated by Qs Ltd Company. Jpmorgan Chase, New York-based fund reported 19,610 shares. Fred Alger Management reported 459,961 shares stake.

The stock increased 6.90% or $1 during the last trading session, reaching $15.49. About 2.23M shares traded or 46.39% up from the average. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has risen 57.40% since February 15, 2017 and is uptrending. It has outperformed by 40.70% the S&P500.

Ironwood Pharmaceuticals, Inc., a commercial biotechnology company, engages in the research, development, and commercialization of human therapeutic products. The company has market cap of $2.32 billion. The firm markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States and Constella name in the European Union; and lesinurad for the treatment of hyperuricemia associated with uncontrolled gout under ZURAMPIC and DUZALLO names. It currently has negative earnings. It has collaboration agreements with Allergan plc and AstraZeneca AB to develop and commercialize linaclotide for the treatment of IBS-C, CIC, and other GI conditions in North America, China, Hong Kong, and Macau; and license agreement with Astellas Pharma Inc. to develop and commercialize linaclotide for the treatment of IBS-C, chronic constipation, and other GI conditions in Japan.

Lsv Asset Management decreased Marathon Petroleum Corporation (NYSE:MPC) stake by 203,960 shares to 3.15M valued at $176.60 million in 2017Q3. It also reduced Sturm Ruger & Company Inc. (NYSE:RGR) stake by 216,500 shares and now owns 75,000 shares. Navigator Holdings Ltd. (NYSE:NVGS) was reduced too.

Since January 23, 2018, it had 0 insider purchases, and 3 selling transactions for $2.87 million activity. Aghili Aziz also sold $418,092 worth of Dana Incorporated (NYSE:DAN) shares. The insider Wallace Mark E sold $1.35M. 33,244 shares valued at $1.10 million were sold by Matthews Dwayne on Tuesday, January 23.

Investors sentiment decreased to 1.03 in Q3 2017. Its down 0.05, from 1.08 in 2017Q2. It worsened, as 21 investors sold DAN shares while 83 reduced holdings. 39 funds opened positions while 68 raised stakes. 137.76 million shares or 2.31% less from 141.01 million shares in 2017Q2 were reported. Deutsche National Bank & Trust Ag stated it has 0.01% of its portfolio in Dana Incorporated (NYSE:DAN). Barclays Public Ltd Co owns 6,009 shares. Bankshares Of America De owns 1.18M shares or 0.01% of their US portfolio. Teachers Retirement Of The State Of Kentucky reported 35,460 shares stake. Renaissance Technologies Limited Com holds 0% or 37,035 shares in its portfolio. Smith Asset Mgmt Group Limited Partnership holds 17,096 shares or 0.02% of its portfolio. Natixis accumulated 27,913 shares or 0.01% of the stock. State Common Retirement Fund has invested 0.03% in Dana Incorporated (NYSE:DAN). Dreman Value Management L L C holds 0.23% in Dana Incorporated (NYSE:DAN) or 14,845 shares. State Treasurer State Of Michigan has invested 0.01% in Dana Incorporated (NYSE:DAN). Millennium Mgmt Lc owns 2.75 million shares or 0.12% of their US portfolio. Mutual Of America Cap Mngmt Limited Liability Co holds 0.05% or 116,509 shares. Ameriprise Finance Inc holds 712,438 shares. Pinnacle Assocs Ltd holds 0.07% or 139,500 shares. Moreover, Tcw has 0.88% invested in Dana Incorporated (NYSE:DAN) for 3.94M shares.

Among 11 analysts covering Dana Holding Corp (NYSE:DAN), 3 have Buy rating, 1 Sell and 7 Hold. Therefore 27% are positive. Dana Holding Corp had 43 analyst reports since September 28, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Barclays Capital on Friday, September 16. The rating was maintained by Barclays Capital with “Equal Weight” on Friday, October 23. Deutsche Bank maintained the stock with “Hold” rating in Friday, October 23 report. The firm has “Outperform” rating by FBR Capital given on Friday, February 19. RBC Capital Markets maintained Dana Incorporated (NYSE:DAN) rating on Friday, October 23. RBC Capital Markets has “Sector Perform” rating and $17 target. Barclays Capital maintained Dana Incorporated (NYSE:DAN) rating on Friday, October 20. Barclays Capital has “Equal-Weight” rating and $28 target. The rating was maintained by Barclays Capital with “Equalweight” on Monday, January 25. The company was initiated on Wednesday, June 21 by CLSA. The firm has “Mkt Perform” rating by FBR Capital given on Thursday, November 10. The rating was maintained by FBR Capital on Friday, October 23 with “Outperform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: